Peptide
CJC-1295
CJC-1295 (GHRH Analog)
Research Use Only · Not for Human Consumption
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The DAC (Drug Affinity Complex) modification in CJC-1295 DAC allows it to bind to albumin after injection, dramatically extending its half-life to approximately 6–8 days compared to native GHRH's half-life of a few minutes. CJC-1295 (no DAC) has a shorter half-life of approximately 30 minutes. Both forms are used to study GHRH receptor signaling.
Key Facts
- Type
- GHRH analog
- Modification
- DAC (albumin-binding) or without DAC
- Half-life with DAC
- ~6–8 days
- Storage
- -20°C lyophilized
Research Applications
- GHRH receptor signaling studies
- GH pulsatility research
- IGF-1 axis studies
- Synergistic research with GHRPs (ipamorelin, GHRP-2)
Frequently Asked Questions
Related Terms
Stock CJC-1295 on Your Research Compound Store
PeptiCommerce provides turn-key access to COA-documented research compounds. Your branded WooCommerce store with P2P and crypto payment support, ready in under 72 hours.
Get Started →